Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2015
03/05/2015WO2015031775A1 Methods and compositions for rna-guided treatment of hiv infection
03/05/2015WO2015031679A2 Modulation of prekallikrein (pkk) expression
03/05/2015WO2015030078A1 Therapeutic agent for ectocornea injury
03/05/2015WO2015028683A1 Rna based method to obtain stably integrated retroviral vectors
03/05/2015WO2015027895A1 Nucleic acid, pharmaceutical composition and uses thereof
03/05/2015WO2015027652A1 A novel antidiabetic drug
03/05/2015US20150064236 Modified polynucleotides for the production of proteins
03/05/2015US20150064215 Therapeutic delivery and expression system, methods and uses thereof
03/05/2015US20150064116 Multilayered magnetic micelle compositions and methods for their use
03/04/2015EP2843049A1 Neuronal differentiation promoter
03/04/2015EP2842964A1 Virtual method of determining a modified mRNA sequence
03/04/2015EP2842577A1 Method for proliferating cardiomyocytes using micro-RNA
03/04/2015EP2841572A2 Genetic correction of mutated genes
03/03/2015US8969544 Combined use of PRAME inhibitors and HDAC inhibitors
03/03/2015US8969543 SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
03/03/2015US8969542 HPV polyepitope constructs and uses thereof
03/03/2015US8969353 Aminoalcohol lipidoids and uses thereof
03/03/2015US8969318 Bispecific aptamers mediating tumour cell lysis
03/03/2015US8969315 Enhancement of placental stem cell potency using modulatory RNA molecules
03/03/2015US8969080 Remedy for the treatment of cardio-vascular diseases or disorders
03/03/2015US8969077 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
03/03/2015US8969076 Method for expression of small RNA molecules within a cell
03/03/2015US8969063 Herpes simplex viruses and methods of viral replication
03/03/2015US8968746 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
03/03/2015US8968719 Live, oral vaccine for protection against Shigella dysenteriae serotype 1
02/2015
02/26/2015WO2015027243A2 Biologically active synthetic nanoparticle constructs and mehtods of use therof
02/26/2015WO2015025995A1 Pharmaceutical composition and method for preventing or treating diseases associated with epilepsy or convulsions by targeting microrna
02/26/2015WO2015025940A1 Novel adenovirus and method for promoting growth thereof
02/26/2015WO2015024667A1 Method for increasing expression of rna-encoded proteins
02/26/2015US20150057339 High molecular weight arginine-grafted bioreducible polymers
02/25/2015EP2839014A1 Composition and methods for highly efficient gene transfer using aav capsid variants
02/25/2015EP2838567A1 Tfeb gene therapy of alpha-1-antitrypsin deficiency
02/24/2015US8962818 Compositions comprising GHRH and GnRH and methods of using the same
02/24/2015US8962591 Compositions and methods for treating cancer
02/24/2015US8962590 Prostate cancer vaccine
02/24/2015US8962587 Gene delivery of OCT4 and SirT1 and pharmaceutical compositions thereof
02/24/2015US8962586 Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
02/24/2015US8962583 Treatment of inflammatory diseases using miR-124
02/24/2015US8962580 Chemical modifications of monomers and oligonucleotides with cycloaddition
02/24/2015US8962546 Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor
02/24/2015US8962332 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
02/24/2015US8962330 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
02/24/2015US8962321 Mesenchymal stromal cells and uses related thereto
02/24/2015US8961959 Glucosylceramide synthase inhibitors and therapeutic methods using the same
02/24/2015US8961956 Mesenchymal stromal cells and uses related thereto
02/24/2015CA2645120C Treatment of cns conditions
02/24/2015CA2640528C Oncolytic adenoviruses for cancer treatment
02/24/2015CA2489467C Humanized monoclonal antibody hpam4
02/19/2015WO2015023937A1 Heterochromatin forming non-coding rnas
02/19/2015WO2015023664A2 Therapeutic treatment for drug poisoning and addiction
02/19/2015WO2015023461A2 Influenza nucleic acid molecules and vaccines made therefrom
02/19/2015US20150050354 Modified polynucleotides for the treatment of otic diseases and conditions
02/19/2015US20150050302 Artificial nucleic acid molecules comprising a 5'top utr
02/19/2015US20150050242 Nipah virus envelope pseudotyped lentiviruses and methods of their use
02/18/2015EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
02/18/2015EP2836240A1 Compositions and methods for treating otitis media and other conditions with inhibitors of cyld
02/18/2015EP2836239A1 Chimeric antigen receptors targeting b-cell maturation antigen
02/18/2015EP2836226A1 Compositions and methods for the treatment of hemoglobinopathies
02/17/2015US8957198 Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna
02/17/2015US8957191 Nucleic acid comprising zwitterionic nucleotides
02/17/2015US8957044 Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)
02/17/2015US8957043 Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2
02/17/2015US8957042 Cancer treatment targeting non-coding RNA overexpression
02/17/2015US8957037 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
02/17/2015US8957036 Targeted delivery of glycine receptors to excitable cells
02/17/2015US8957035 Toll like receptor (TLR) stimulation for ocular angiogenesis and macular degeneration
02/17/2015US8957034 Drugs and gene carrier particles that rapidly move through mucous barriers
02/17/2015US8957015 Tumor suppressor gene p47ING3
02/17/2015US8956572 Single use system for sterilely producing lipid-nucleic acid particles
02/17/2015CA2494384C A segment of glycosylation-deficient hgf .alpha.-chain
02/12/2015WO2015021457A2 Compounds and methods for modulation of dystrophia myotonica-protein kinase (dmpk) expression
02/12/2015WO2015020993A2 RNAi COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA
02/12/2015WO2015020522A1 Recombinant aav-crumbs homologue composition and methods for treating lca-8 and progressive rp
02/12/2015WO2015020215A1 Lentiviral vector thtd, aging agent, cancer inhibitor, and medicinal composition containing said thtd, protein packaged in viruslike hollow particle, and production method for viruslike hollow particle
02/12/2015WO2015020194A1 Antisense oligonucleotide against acsl1
02/12/2015WO2015020122A1 Urothelial cancer diagnosis and therapeutic agent
02/12/2015WO2015020026A1 Nucleic acid-encapsulating polymer micelle complex and method for producing same
02/12/2015WO2015019505A1 Lentiviral vector thtd and senescence-promoting material containing thtd
02/12/2015WO2015019124A1 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
02/12/2015WO2015018860A1 New peptides having specificity for the lungs
02/12/2015WO2015018698A1 Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
02/12/2015WO2015018503A1 Compositions and methods for treatment of muscular dystrophy
02/12/2015WO2015018375A1 Depression regulatory factor and applications thereof
02/12/2015WO2015018331A1 Minicircle dna recombinant parental plasmid having genetically engineered antibody gene expression cassette, a minicircle dna having the expression cassette, and applications
02/12/2015US20150047064 INHIBITING GENE EXPRESSION WITH dsRNA
02/12/2015US20150045536 Universal carrier for targeting molecules to gb3 receptor expressing cells
02/12/2015US20150045417 A novel drug delivery system based on jcv-vlp
02/12/2015US20150044277 Modified polynucleotides encoding caspase 3
02/11/2015EP2834293A2 Additive for use in wash step of pet recycling process
02/11/2015EP2833923A1 Modified polynucleotides for the production of proteins
02/11/2015EP2833922A2 In vivo production of proteins
02/11/2015EP2833921A2 Modified polynucleotides for the production of secreted proteins
02/11/2015EP2833920A2 Modified polynucleotides for the production of biologics and proteins associated with human disease
02/11/2015EP2833869A1 Method of preparing composition for delivering an anionic drug
02/11/2015CN104342453A 含基因工程抗体基因表达盒的微环dna重组母质粒、含该表达盒的微环dna及应用 Microring dna parent plasmid containing the genetically engineered recombinant antibody gene expression cassette, the expression cassette containing the microring dna and Applications
02/11/2015CN104342440A CDKL1基因及其siRNA和应用 CDKL1 siRNA and gene and its application
02/11/2015CN104338150A Pcbp1基因制备放疗增敏试剂盒的应用 Preparation Pcbp1 gene radiosensitization application kit
02/11/2015CN104338149A Isl1基因及其表达产物在促进HCN4表达中的应用 Isl1 gene and its expression products in the promotion of HCN4 expression Applications
02/11/2015CN104338148A 基于山梨糖醇-多胺聚合物的基因传递系统用于肺癌基因治疗 Based on sorbitol - polyamine polymer gene delivery system for gene therapy for lung cancer
02/11/2015CN104338135A 抑郁症的调节因子及其应用 Adjustment factor for depression and its application
1 2 3 4 5 6 7 8 9 10 11 ... 870